This trend of a longer PFS in VHL mutation patients was also observed in the DDR mutant and co-mutant subgroups, but did not reach statistical significance ( p = 0.085, 0.085).
← all excerpts
VHL and DNA damage repair pathway alterations as potential clinical biomarkers for first-line TKIs in metastatic clear cell renal cell carcinomas.
1
0.0850
0.0850